patch pipettes 5–10 mω Search Results


90
Becton Dickinson falcon serological pipet
Falcon Serological Pipet, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc05498237-137-8-11?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
falcon serological pipet - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
METTLER TOLEDO manual pipette
Manual Pipette, supplied by METTLER TOLEDO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc03641661-282-109-113?v=METTLER+TOLEDO
Average 90 stars, based on 1 article reviews
manual pipette - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Harvard Bioscience borosilicate glass capillaries
Borosilicate Glass Capillaries, supplied by Harvard Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/10__3233_slash_bpl___190097-37-83-97?v=Harvard+Bioscience
Average 90 stars, based on 1 article reviews
borosilicate glass capillaries - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Siltronix Inc zero background silicon wafer (510)
Zero Background Silicon Wafer (510), supplied by Siltronix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/10__1039_slash_d0en00764a-124-21-27?v=Siltronix+Inc
Average 90 stars, based on 1 article reviews
zero background silicon wafer (510) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Corning Life Sciences transwell filters
The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in <t>Transwell</t> culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons
Transwell Filters, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc04936015-35-26-30?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
transwell filters - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

95
Eppendorf AG pipette tip
The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in <t>Transwell</t> culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons
Pipette Tip, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pm26071038-153-5-10?v=Eppendorf+AG
Average 95 stars, based on 1 article reviews
pipette tip - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

93
Greiner Bio serological pipettes
The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in <t>Transwell</t> culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons
Serological Pipettes, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc10044574-416-7-11?v=Greiner+Bio
Average 93 stars, based on 1 article reviews
serological pipettes - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Becton Dickinson 5 or 10 ml serological pipettes
The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in <t>Transwell</t> culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons
5 Or 10 Ml Serological Pipettes, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc03151526-170-4-6?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
5 or 10 ml serological pipettes - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
METTLER TOLEDO p1000 pipette
The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in <t>Transwell</t> culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons
P1000 Pipette, supplied by METTLER TOLEDO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc04367231-75-16-18?v=METTLER+TOLEDO
Average 90 stars, based on 1 article reviews
p1000 pipette - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson disposable plastic pipette bd falcon serological pipet; in 1/10
The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in <t>Transwell</t> culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons
Disposable Plastic Pipette Bd Falcon Serological Pipet; In 1/10, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc04467829-75-7-10?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
disposable plastic pipette bd falcon serological pipet; in 1/10 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Corning Life Sciences serological pipettes
The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in <t>Transwell</t> culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons
Serological Pipettes, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc10444976-46-52-54?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
serological pipettes - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

98
Sutter Instrument Company borosilicate glass pipettes
The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in <t>Transwell</t> culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons
Borosilicate Glass Pipettes, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/patch+pipettes+5%E2%80%9310+m%CF%89/pmc06376993__NIHMS1519907___supplement___2-289-0-7?v=Sutter+Instrument+Company
Average 98 stars, based on 1 article reviews
borosilicate glass pipettes - by Bioz Stars, 2026-07
98/100 stars
  Buy from Supplier

Image Search Results


The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in Transwell culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons

Journal: Arthritis Research & Therapy

Article Title: H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis

doi: 10.1186/s13075-016-1053-7

Figure Lengend Snippet: The impact of trimethylated histone 3 lysine 27 (H3K27me3) inhibition on extracellular matrix production and chondrogenic gene expression. a Addition of GSK-J4 to chondrogenic media of human mesenchymal stem cells (MSCs) caused a reduction in collagen production as measured by Nile Red incorporation relative to viable cells (day 7, n = 3 individuals, 3 technical replicates per condition). b Jumonji domain-containing 3 ( JMJD3 ) expression was increased during chondrogenic differentiation of MSCs to form cartilage discs. Assessment of gene expression at days 7 and 14 of chondrogenesis revealed that H3K27me3 inhibition through GSK-J4 addition to chondrogenic media resulted decreased expression of SRY (sex determining region Y)-box 9 ( SOX9 ), collagen type II, alpha 1 ( COL2A1 ), aggrecan ( ACAN ) and collagen type X, alpha 1 ( COL10A1 ) ( c , d , f , g ) and increased expression of collagen type I, alpha 1 ( COL1A1 ) (e) ( n = 3 individuals). h MSCs were pre-treated with small interfering RNA (siRNA) against JMJD3 , lysine (K)-specific demethylase 6A ( UTX ) or non-targeting siRNA control prior to chondrogenic induction in Transwell culture. RNA was extracted and cDNA synthesized at day 7 of chondrogenesis, and expression of SOX9 , ACAN COL2A1 , COL10A1 and COL1A1 was assessed by quantitative reverse transcription polymerase chain reaction ( n = 4 patients, n = 2 technical replicates per patient). Dashed line represents expression level following MSC treatment with non-targeting siRNA control. i Proteoglycan content at day 14 in cartilage discs generated in Transwell cultures was reduced following addition of GSK-J4 to chondrogenic medium ( n = 3 individuals). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Data are presented as individual data points for biological replicates showing mean ± 95 % CI. a and i t test, b – h analysis of variance with Dunnett’s correction for multiple comparisons

Article Snippet: For cartilage disc generation, MSCs were resuspended in chondrogenic medium and 100 μl of MSCs at 5 × 10 6 cells/ml were pipetted onto 6.5-mm, 0.8-μm pore polycarbonate Transwell filters (Corning Costar, Corning, NY, USA) in a 24-well plate, centrifuged (200 × g , 5 min) before addition of 500 μl of chondrogenic medium to the lower well.

Techniques: Inhibition, Gene Expression, Expressing, Small Interfering RNA, Control, Synthesized, Reverse Transcription, Polymerase Chain Reaction, Generated